日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

曲妥珠单抗德鲁替康治疗HER2表达实体瘤患者的疗效和安全性:DESTINY-PanTumor02 II期试验的主要结果

Meric-Bernstam, Funda; Makker, Vicky; Oaknin, Ana; Oh, Do-Youn; Banerjee, Susana; González-Martín, Antonio; Jung, Kyung Hae; Ługowska, Iwona; Manso, Luis; Manzano, Aránzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Ma, Yan; Puvvada, Soham; Shire, Norah; Lee, Jung-Yun

Association between immune-mediated adverse events and efficacy in metastatic non-small-cell lung cancer patients treated with durvalumab and tremelimumab

免疫介导不良事件与接受度伐利尤单抗和曲美利木单抗治疗的转移性非小细胞肺癌患者的疗效之间的关联

Dey, Agnish; Austin, Matthew; Kluger, Harriet M; Trunova, Nataliya; Mann, Helen; Shire, Norah; Morgan, Claire; Zhou, Diansong; Mugundu, Ganesh M

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world

转移性非小细胞肺癌中STK11(LKB1)突变:真实世界的预后价值

Shire, Norah J; Klein, Alyssa B; Golozar, Asieh; Collins, Jenna M; Fraeman, Kathy H; Nordstrom, Beth L; McEwen, Robert; Hembrough, Todd; Rizvi, Naiyer A

SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

SUPREME-HN:一项回顾性生物标志物研究,旨在评估PD-L1表达在复发性和/或转移性头颈部鳞状细胞癌患者中的预后价值

Pai, Sara I; Cohen, Ezra E W; Lin, Derrick; Fountzilas, George; Kim, Edward S; Mehlhorn, Holger; Baste, Neus; Clayburgh, Daniel; Lipworth, Loren; Resteghini, Carlo; Shara, Nawar; Fujii, Takashi; Zhang, Jun; Stokes, Michael; Wang, Huifen; Twumasi-Ankrah, Philip; Wildsmith, Sophie; Khaliq, Asud; Melillo, Giovanni; Shire, Norah

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

非小细胞肺癌中程序性死亡配体-1 (PD-L1) 蛋白表达、突变及生存的分子流行病学分析

Schabath, Matthew B; Dalvi, Tapashi B; Dai, Hongyue A; Crim, Alan L; Midha, Anita; Shire, Norah; Gimbrone, Nicholas T; Walker, Jill; Greenawalt, Danielle M; Lawrence, David; Rigas, James R; Brody, Robert; Potter, Danielle; Kumar, Naveen S; Huntsman, Shane A; Gray, Jhanelle E

HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles.

HBV 和 HIV/HBV 感染患者的免疫耗竭和细胞凋亡血清生物标志物谱存在差异

Shata Mohamed Tarek M, Abdel-Hameed Enass A, Rouster Susan D, Yu Li, Liang Meina, Song Esther, Esser Mark T, Shire Norah, Sherman Kenneth E

Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide

铜绿假单胞菌菌血症患者对治疗性抗体靶点PcrV和Psl胞外多糖表现出非保护性抗体滴度。

Thaden, Joshua T; Keller, Ashley E; Shire, Norah J; Camara, M Margarita; Otterson, Linda; Huband, Mike; Guenther, Caitlin M; Zhao, Wei; Warrener, Paul; Stover, C Kendall; Fowler, Vance G Jr; DiGiandomenico, Antonio

Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis

循环真菌生物标志物与侵袭性曲霉病临床结局的相关性

Neofytos, Dionysios; Railkar, Radha; Mullane, Kathleen M; Fredricks, David N; Granwehr, Bruno; Marr, Kieren A; Almyroudis, Nikolaos G; Kontoyiannis, Dimitrios P; Maertens, Johan; Fox, Rebecca; Douglas, Cameron; Iannone, Robert; Kauh, Eunkyung; Shire, Norah

Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients

HIV/丙型肝炎病毒合并感染者和丙型肝炎病毒单一感染者接受重复肝活检的意愿

Amorosa, Valerianna K; Aibana, Omowunmi; Shire, Norah J; Dorey-Stein, Zachariah; Ferrara, Thomas; Gilmore, Joanne; Kostman, Jay R; Lo Re, Vincent 3rd

Metaprotein expression modeling for label-free quantitative proteomics

用于无标记定量蛋白质组学的元蛋白质表达模型

Lucas, Joseph E; Thompson, J Will; Dubois, Laura G; McCarthy, Jeanette; Tillmann, Hans; Thompson, Alexander; Shire, Norah; Hendrickson, Ron; Dieguez, Francisco; Goldman, Phyllis; Schwarz, Kathleen; Patel, Keyur; McHutchison, John; Moseley, M Arthur